The rapid spread of ZIKV within the Americas has unveiled microcephaly 1 and Guillain-Barré syndrome 2,3 as ZIKVassociated neurological complications. Recent reports have also indicated other neurological manifestations to be associated with ZIKV, including myelitis 4 , meningoencephalitis 5 and fatal encephalitis 6 . Here, we investigate the neuropathogenesis of ZIKV infection in type I interferon receptor IFNAR knockout (Ifnar1 −/− ) mice, an infection model that exhibits high viral burden within the central nervous system. We show that systemic spread of ZIKV from the site of infection to the brain requires Ifnar1 deficiency in the haematopoietic compartment. However, spread of ZIKV within the central nervous system is supported by Ifnar1-deficient non-haematopoietic cells. Within this context, ZIKV infection of astrocytes results in breakdown of the blood-brain barrier and a large influx of CD8 + effector T cells. We also find that antiviral activity of CD8 + T cells within the brain markedly limits ZIKV infection of neurons, but, as a consequence, instigates ZIKV-associated paralysis. Taken together, our study uncovers mechanisms underlying ZIKV neuropathogenesis within a susceptible mouse model and suggests blood-brain barrier breakdown and T-cell-mediated neuropathology as potential underpinnings of ZIKV-associated neurological complications in humans.
the low levels of ZIKV RNA detected within the brain of the other chimaeras may be representative of virus within residual blood. Nevertheless, these data indicate that, while systemic spread of ZIKV requires Ifnar1 deficiency within the haematopoietic compartment, Ifnar1 deficiency within haematopoietic cells is not sufficient to cause neurological viral amplification and disease.
Our data are consistent with recent work showing viraemia, but limited brain infection and lack of neuropathology, in LysMCre + Ifnar1 fl/fl mice 11 . Moreover, our data indicate that Ifnar1dependent block of ZIKV within brain non-haematopoietic cells controls the viral replication and associated neurological disease manifestation of a ZIKV infection. To identify the cell types that support ZIKV replication in the central nervous system (CNS), we conducted immunofluorescence staining of ZIKV-infected adult Ifnar1 −/− brains at 7 days post infection (d.p.i.), a time when the majority of infected mice present with neurological complications and a high viral load is measured. Despite the multiple cell types evaluated (microglia and oligodendrocytes; Supplementary  Fig. 1a,b ), we found that ZIKV infection is largely confined to astrocytes and, to a lesser extent, within neurons of the cerebral cortex ( Fig. 2a ). This tropism was evident in various regions within the CNS, including the cerebellum, brain stem and spinal cord ( Supplementary Fig. 2 ). Despite a large number of inflammatory cells within the meninges, we did not find many positive ZIKV cells within this region at 7 d.p.i. ( Supplementary Fig. 1c ).
Astrocytes extend their end foot processes to provide integral support for the blood-brain barrier (BBB) 12 . Indeed, we observed prominent infection of the astrocyte end feet surrounding blood vessels in the CNS (Fig. 2c ). We predicted that ZIKV infection of astrocytes might lead to increased vascular permeability. To probe BBB breakdown, we stained for the presence of mouse immunoglobulin G (IgG), which is normally blocked from accessing the CNS parenchyma by the BBB. We found bright IgG staining within infected brains of Ifnar1 −/− mice, but not the Ifnar1-competent, wild-type (WT) ZIKV infected mice or the mock-infected Ifnar1 −/− controls (Fig. 2b) . Consistently, intravenous injection of fluorescently labelled dextran at the peak of ZIKV-disease presentation provided functional demonstration of a ZIKV-induced BBB disruption ( Fig. 2d , quantified in Supplementary Fig. 3c ). Furthermore, areas where increased vascular permeability was detected (by evidence of leaky dextran) corresponded to regions where astrocyte foot process lining was fragmented ( Supplementary Fig. 3 ). Analysis of the brain sections of bone marrow chimaeric mice corroborated the stromal dependence in eliciting BBB breakdown, as Ifnar1 −/− → Ifnar1 −/− bone marrow chimaeric mice were the only combination to exhibit Letters NATuRe MICRoBIoloGy positive IgG staining within the brain ( Supplementary Fig. 4 ). Our data therefore suggest that type I IFN signalling within astrocytes blocks their infection by ZIKV and prevents BBB breakdown. The neuroprotective role of the type I IFN cascade within astrocytes has recently been described during the infection of another flavivirus, West Nile virus 13 . Astrocyte-specific Ifnar1-dependence for BBB leakage in ZIKV infection should be examined in future studies.
Histological analysis of ZIKV-infected Ifnar1 −/− brains as compared to Ifnar1-competent, WT infected and mock, uninfected Ifnar1 −/− mice indicated a vast infiltration of leukocytes at 7 d.p.i. (Fig. 3a ) (CD45 + , Fig. 3b ). Flow cytometry analysis of single-cell suspensions of infected and mock Ifnar1 −/− brains further confirmed a significant increase in CD45 + cells at 7 d.p.i. when compared to both mock, uninfected, but also within ZIKV-infected brains at 5 d.p.i. (Fig. 3c) . Notably, the population of infiltrating immune cells largely comprised T cells (CD3 + ) at 7 d.p.i., which only served as a minority population at 5 d.p.i. (Fig. 3d ). Further analysis indicated that the majority of CD3 + cells were CD8 + effector T cells, as analysed by flow cytometry (Fig. 3e ), and immunofluorescence staining revealed that many of these cells were perforin-positive ( Fig. 3f ). This result is consistent with previous work showing CD8 + T cell infiltration within the brains of ZIKV-infected immune-competent neonate C57BL/6 mice without Ifnar1 manipulation 14 . Because we find that the vast infiltration of effector T cells coincides with CNS pathogenesis, our data suggest that either the effector T cells are reaching the brain too late to control virus replication or that their antiviral actions may be immunopathogenic.
To understand the effects of T cell infiltration on viral load and neuropathology of a ZIKV infection, we depleted T cells with antibodies. Notably, depletion of CD8 + T cells, but not CD4 + T cells, resulted in a significant increase in survival ( Fig. 4a ). However, viral 
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NATuRe MICRoBIoloGy load at 7 d.p.i. indicated a significantly higher viral load in the brain of the CD8 + T-cell-depleted animals than in those intact in CD8 + T cells (Fig. 4d ). The higher viral load in CD8 T-depleted mice at 7 d.p.i. was corroborated by ZIKV immunofluorescence within CD8 + T cell intact versus depleted brain tissues ( Fig. 4f ). These data are consistent with recent studies demonstrating elevated ZIKV replication in CD8-depleted or CD8-knockout anti-Ifnar1 treated animals 11 or in Rag1 −/− mice 15 . In contrast, hindlimb paralysis was strikingly abrogated in CD8-depleted mice (Fig. 4b ), which were euthanized due to weight loss greater than 20% rather than onset of paralysis, as was the case within the undepleted or CD4-depleted mice ( Fig. 4c and Supplementary Fig. 5 ). The CD8-depleted mice had, in addition to significant weight loss, symptoms of illness including ruffled fur, hunched backs and/or tremors late in infection. Dual depletion of CD4 + and CD8 + T cells resulted in an intermediate phenotype with a significant increase in survival, but not to the same extent as seen within solely CD8 T-depleted mice. Consistent with the intermediate increase in survival, only one of the eight dual-depleted mice developed hindlimb paralysis. Interestingly, all CD4-depleted mice developed hindlimb paralysis, suggestive of a potential regulatory role of CD4 + T cells. Within this vein, we probed for the presence of Foxp3 + regulatory T cells within the CNS. Increased number of Foxp3 + regulatory T cells were found within ZIKV-infected animals compared to mock-infected Ifnar1 −/− mice in the brain, and comparable levels of Tregs were found in the spleen (Fig. 4e ). These data suggest that although CD8 T cells cause neuropathology, CD4 + Tregs dampen the immunopathology caused by CD8 T cells.
We also investigated ZIKV-infected cell types within the brain and found that the percentage of ZIKV-positive neurons increased drastically within the CD8-depleted animals as compared to the CD8 + T cell intact mice at 7 d.p.i. (Fig. 4e ). This difference was determined to be quantitatively significant in both the cerebral cortex and the distal spinal cord (Fig. 4g ). Furthermore, we found positive activated caspase 3 staining within the NeuN + neurons with fragmented nucleus (via 4′ ,6-diamidino-2-phenylindole (DAPI) staining) in the ZIKV-infected brains and spinal cords at 7 d.p.i. within CD8 T cell intact mice ( Supplementary Fig. 6b ,c, respectively, white arrow). Some of the dying neurons expressed low levels of NeuN ( Supplementary Fig. 6b , inset, yellow arrow). We also observed activated caspase 3 staining in rare non-neuronal cells ( Supplementary Fig. 6b ,c, grey arrow). In contrast, activated caspase 3 staining was completely absent in the CNS of CD8-depleted mice at 7 d.p.i. ( Supplementary Fig. 6a ). Finally, we were able to visualize an immunological synapse of cytolytic cells (perforin positive) with neurons within the brain of ZIKV-infected mice ( Supplementary  Fig. 6d ). These data revealed that CD8 + T-cell-mediated lysis of ZIKV-infected neurons, while controlling the viral load, leads to hindlimb paralysis.
In summary, our study in Ifnar1 −/− deficient mice has demonstrated that ZIKV infects circulating leukocytes in order to become blood-borne. Once in circulation, ZIKV-infected, bonemarrow-derived cells facilitate viral spread to various tissues 
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and assume organ-specific virus replication. Within the CNS, Ifnar1 signalling within brain non-haematopoietic cells is able to block ZIKV spread. In the absence of Ifnar1, astrocytes become infected with ZIKV, resulting in a loss of the BBB. BBB breakdown is accompanied by a large influx of infiltrating cells into the CNS. In particular, CD8 + T cells infiltrate into the brain and are able to limit ZIKV replication within neurons. However, this antiviral process comes at the cost of neuropathogenesis, leading to hindlimb paralysis. ZIKV infection of the Ifnar1-deficent mouse allows us to model ZIKV pathogenesis under circumstance of high viral burden within the CNS where innate resistance is inefficient or impaired. Such from an analysis of 1.5 million whole brain cells. CD45 + cells were further analysed for the percentage of CD3 + and F4/80 + cells in 1.5 million whole brain cells (d) and quantification of CD4, CD8 through flow cytometry of isolated leukocytes from the brain (e). *P < 0.05; **P < 0.01; ***P < 0.001 (two-tailed unpaired Student's t-test).
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conditions might mimic the settings of neonates 16 , the elderly 17 and immunosuppressed individuals, where innate resistance is suboptimal, resulting in overdrive of compensatory immune effector mechanisms. Consistent with previous work 11, 15 , our findings indicate an antiviral role for CD8 T cells in ZIKV infection. Yet, under conditions of high viral burden within the CNS, in the Ifnar1 −/− mouse model this protection resulted in lethal immunopathology. A recent postmortem analysis of human neonates with congenitally acquired ZIKV found leukocyte aggregation near blood vessels or perivascular cuffing as a common phenotype within the brains analysed 18 . Our data are strikingly similar in that we observed perivascular infiltration of T cells within the brains of the Ifnar1-deficent mice (Fig. 2a ). Additionally, 'red neurons' , a pathological finding of apoptotic neurons within histology slides, were found within congenitally infected neonatal brains, indica-tive of neuronal apoptosis/necrosis 18 , a phenotype found within Ifnar1 −/− mice ( Supplementary Fig. 6 ). Finally, work with primary developing human brain tissue found ZIKV to target astrocytes for viral replication 19 , also consistent with our work. These similarities in pathology suggest that ZIKV infection of the Ifnar1deficent mouse may serve to model some aspects of congenitally acquired ZIKV infection. However, whether CD8 T cells play a role in neonatal brain immunopathology following congenital ZIKV infection remains to be determined. Our results suggest a potential involvement of adaptive immune response as a basis for apoptosis of infected neurons, leading to immunopathology in the setting of impaired innate resistance. Our data thereby provide a compelling basis to investigate the role of T cells and BBB breakdown within ZIKV-induced neurological complications that follow ZIKV infection in humans 20 . Isotype control (14) Isotype control CD8 + depleted (9) CD8 + depleted CD4 + depleted (9) CD4 + depleted CD8 + and CD4 + depleted (8) CD8 + and CD4 + depleted 
Fig. 4 | Antiviral activity of effector CD8 + T cells within the brain limits ZIKV replication within neurons, but instigates ZIKV-associated paralysis.
Ifnar1 −/− mice were injected with depletion antibodies for CD8 (n = 9), CD4 (n = 9), CD4 and CD8 (n = 8) or with isotype control (n = 14) − 1, 4 and 9 d.p.i. with 1 × 10 6 p.f.u. of ZIKV intra-footpad in three separate experiments. a-c, Survival (a) and development of hindlimb paralysis (b) were monitored, and weight at time of sacrifice due to development of moribund state (onset of paralysis or > 20% weight loss) was determined (c). d, At 7 d.p.i. (and 11 d.p.i. for CD8-depleted), the viral load in tissue homogenates of brain and spleen was determined. Data are presented as mean ± s.d. e, Intracellular Foxp3 + cells were analysed via flow cytometry within ZIKV-infected (n = 8) and mock (n = 4) brains in two separate experiments. f, Frozen sections of the brain, specifically the cerebral cortex (at 7 d.p.i.), were stained with antibodies against NeuN and ZIKV with nuclei depicted by DAPI stain (blue; scale bars, 50 µ m). g, ZIKV positive (ZIKV+ ) neurons within the cortex and distal spinal cord were quantified in CD8 intact and depleted murine tissues. *P < 0.05; **P < 0.01; ***P < 0.001 (two-tailed unpaired Student's t-test or log-rank test for survival curve).
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Methods
Mice. Ifnar −/− mice (32045-JAX) and CD45.1 mice (stock #002014) were purchased from the Jackson Laboratory and C57BL/6 mice (strain code #027) from Charles River. Ifnar −/− and C57BL/6 mice were subsequently bred and housed at Yale University. Male and female mice were between six and eight weeks of age at the initiation of all experiments conducted. No randomization protocol or blinding was used. The sample size was designed to provide statistical significance with a strict minimum of three mice per condition. All animal procedures were completed in compliance with approved Yale Institutional Animal Care and Use Committee protocols.
Virus and cells. The ZIKV Cambodian FSS13025 strain (from the World Reference Center for Emerging Viruses and Arboviruses at University of Texas Medical Branch, Galveston) was used for all experiments. ZIKV stocks were grown in C636 cells and titred by plaque assay within Vero cells (ATCC CCL-81), as previously described 21 . C6/36 mosquito cells (Aedes albopictus) (ATCC CRL-1660) were maintained in Dulbecco's modified Eagle's medium (Gibco) supplemented with 10% heat-inactivated fetal bovine serum, 1% penicillin/streptomycin (Gibco) and 1% tryptose phosphate broth (Sigma) at 30 °C. Vero cells were maintained at 37 °C in Dulbecco's modified Eagle's medium (Gibco) supplemented with 10% heat-inactivated fetal bovine serum, 1% penicillin/streptomycin (Gibco). Cell lines were authenticated by morphology and were routinely tested for mycoplasma contamination.
In vivo experiments. Mice were infected with 1 × 10 6 plaque-forming units (p.f.u.) ZIKV via intra footpad injection. For bone marrow chimaera studies, mice were irradiated with two doses of 475 cGy (total 950 cGy) and reconstituted with 1 × 10 6 WT or Ifnar1 −/− bone marrow cells. The mice were used for experiments eight weeks after bone marrow transplantation. Chimaeras were checked for efficiency of reconstitution through the use of congenic bone marrow transfer. Reconstitution was determined to be 91-93% efficient in the Ifnar1 −/− → WT mice and 93-95% efficient within the WT → Ifnar1 −/− mice. For BBB breakdown assay with ZIKV or PBS (mock), Oregon green 488-conjugated dextran (70 kDa; 5 mg ml −1 , 200 μ l per mouse) was injected intravenously at 7 d.p.i. Forty-five minutes later, the mice were killed for immunohistochemical analysis. For depletion studies, Ifnar −/− mice were injected intravenously with 300 μ g of anti-CD4 (GK1.5;BioXCell) and/or anti-CD8 (YPT; BioXCell) antibody at days − 1, 4 and 9 post ZIKV infection. Depleted mice demonstrated 90-95% efficiency of depletion treatment on day 7 post ZIKV infection. All antibodies for depletion studies were purchased from BioXCell. Mice were monitored for clinical illness and were euthanized before reaching the moribund state (onset of hindlimb paralysis (the inability to move hind legs) and/ or > 20% weight loss) for humane reasons.
Virus quantification.
To determine ZIKV viraemia, 50-100 μ l of blood was collected via retro-orbital bleed at indicated time points post-infection. Total RNA was extracted using Trizol (Thermo Fischer Scientific) extraction followed by purification with an RNeasy Mini Kit (Qiagen). To determine the levels of virus in tissues, mice were euthanized and tissues were collected and extracted in Trizol. cDNA was synthesized using an iScript cDNA synthesis kit (Bio-Rad) and quantitative PCR was performed using SYBR-Green (Bio-Rad) or PrimeTime master mix (Integrated DNA Technologies) on a CFX Connect instrument (Bio-Rad). ZIKV RNA was detected using primers designed to NS5, with the limit of detection determined as previously described 21 .
Immunofluorescence. Organs were fixed in 4% paraformaldehyde (PFA) for 24 h or IHC zinc fixative (BD Pharmingen) for anti-perforin stained tissues. The fixed tissues were then sucrose-sedimented in 10, 20 and 30% steps before being embedded in optimum cutting temperature (O.C.T.) medium (Tissue Tek). Frozen sections (5-7 μ m thickness) were cut and left to dry at ambient temperature. These tissues were then stained with primary antibodies: cleaved caspase 3 (Cell Signaling Technology), CD31 (Novus Biologicals), CD45 (Novus Biologicals), glial fibrillary acidic protein (GFAP; Agilent Technologies), rabbit-neuronal marker (NeuN; Cell Signaling Technology), guinea pig-NeuN (EMD Millipore), rat anti-perforin (Novus Biologicals) and anti-ZIKV rat serum 22 after rehydration with PBS (2× for 10 min) and permeabilization with PBST (3× for 10 min) at room temperature overnight. Slides were washed and incubated with appropriate secondary prior to a final wash series and incubation with DAPI, before mounting with SlowFade Diamond Antifade (Fisher Scientific Company). Stained tissues were then analysed by fluorescence microscopy (BX51; Olympus) or confocal microscopy (TCS SP2; Leica).
Flow cytometry. The preparation of single-cell suspensions from brain tissues was completed as previously described 23 using the following e-Bioscience or Biolegend antibodies: CD45.2 (104 and 30-F11), CD45.1 (A20), CD4 (RM4-5 and GK1.5), CD8 (53-6.7), CD3 (145-2C11 and 17A2), F4/80 (BM8), CD25 (PC61), GITR (DTA-1), CD127 (A7R34), FoxP3 (FJK-165) and isotype (eBRG1). Aqua live/dead stain (ThermoFisher) and a FoxP3 intracellular staining kit (eBioscience) were used. Multiparameter analyses were performed on an LSR II flow cytometer (BD Biosciences) and analysed using FlowJo software (Tree Star).
Statistical analysis. Survival curves were analysed using a log-rank test. Variable comparisons were completed using a two-tailed unpaired Student's t-test within GraphPad Prism. We used a minimum of three animals per condition within any experiment. Data are represented as individual data points ± s.d. (or ± s.e.m. for more than seven data points), as stated in figure legends. 
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